UNSPSC 51162506: Ammonium chloride/potassium guaiacolsulfonate/terpin hydrate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE302. This VA Drug Class (RE302) classifies this compound as belonging to the group NON-OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51162506 Ammonium chloride/potassium guaiacolsulfonate/terpin hydrate is a Commodity code representing pharmaceutical and healthcare products that state and local governments procure for correctional health systems and community health initiatives. The recent solicitation activity under this code reflects procurement of parenteral products, including intravenous solutions, parenteral nutrition preparations, and ancillary healthcare supplies used in institutional medical settings. State and local issuing bodies soliciting under the code include state departments of corrections and county health authorities, which typically manage these supplies for incarcerated populations and public health programs. The Washington State Department of Corrections and Seminole County, Florida represent the issuing-body mix in the recent record.

The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, with a response deadline of October 7, 2026 at 4:00 PM PST, seeking parenteral products, services, and equipment—including TPN and PPN solutions, intravenous solutions, and controlled substances—for delivery to eight correctional facilities across three regional clusters (West, Central, and East). The solicitation encourages participation from small businesses, minority-owned businesses, women-owned businesses, and veteran-owned businesses under Washington's Chapter 39.19 RCW and an aspirational 5% Small and Diverse Business Goal; DOC anticipated selecting up to three contractors per region with a contract term of November 26, 2026 through June 30, 2030 and fixed pricing for the initial two years. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries, though the recorded response deadline (July 26, 2023) appears inconsistent with the posting date. Recent activity shows Washington state and Florida as primary jurisdictions, with the code reflecting procurement concentrated in correctional and public health system support.